文献速递乳腺癌放疗

乳腺癌乳房切除术后放疗后自体与假体乳房重建的长期结局

Long-Term Outcomes After Autologous or Tissue Expander/Implant-Based Breast Reconstruction and Postmastectomy Radiation for Breast Cancer.
PubMed 文献 · Pract Radiat Oncol · 2019-06-22

结果显示,无论即刻还是延迟,假体重建的再次手术并发症率和重建失败率均高于自体重建;假体重建、BMI≥30和吸烟是再次手术并发症的预测因素,假体重建、糖尿病和高血压是重建失败的预测因素。

要点

  • 假体重建(TE/I)的5年再次手术并发症率(即刻38%、延迟70%)和重建失败率(即刻22%、延迟56%)均高于自体重建。
  • TE/I、BMI≥30和吸烟是再次手术并发症的独立预测因素。
  • TE/I、糖尿病和高血压是重建失败的独立预测因素;排除感染所致失败后四组失败率无显著差异。

核心结论

  • 在PMRT背景下,即刻和延迟TE/I重建的再次手术并发症率和重建失败率均高于自体重建。
  • 患者因素应指导重建技术的选择。
  • 降低TE/I重建失败率应聚焦于减少感染风险。

研究设计与样本

  • 重建按时机分为即刻(与乳房切除同日、随后PMRT)和延迟(PMRT之后)。
  • 采用Kaplan-Meier计算累积发生率、log-rank检验比较、逻辑回归分析相关变量。

关键数值与推荐

  • 再次手术并发症定义:因感染、裂开、坏死、血肿或疝(自体重建)以及挤出、渗漏或挛缩(TE/I)而计划外返回手术室。
  • 重建失败定义:计划外转为其他重建技术或转为平胸壁。
  • TE/I重建、BMI≥30、吸烟与再次手术并发症显著相关;TE/I重建、糖尿病、高血压与重建失败显著相关。

临床怎么用

  • 接受PMRT的患者选择重建方式时,应权衡TE/I与自体重建的并发症和失败风险。
  • 对BMI≥30、吸烟、糖尿病或高血压患者,应充分告知TE/I重建的高风险并考虑个体化选择。
  • TE/I重建患者应重点预防和管控感染以降低重建失败率。

局限性

  • 数据来自2000至2008年,放疗技术和重建实践可能已发生变化。
  • 原文未报告各组具体样本量、置信区间及更多混杂因素调整细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The toxicity profile of breast reconstruction with postmastectomy radiation therapy (PMRT) varies by technique and timing, and long-term data are limited. We compared rates of complications requiring reoperation (CRR) and reconstruction failure (RF) between immediate autologous reconstruction (I-AR), immediate tissue expander/implant reconstruction (I-TE/I), delayed autologous reconstruction (D-AR), and delayed tissue expander/implant reconstruction (D-TE/I) in patients receiving PMRT. METHODS AND MATERIALS: Patients who received autologous reconstruction (AR) or tissue expander/implant reconstruction (TE/I) and PMRT between 2000 to 2008 were included. Reconstruction was immediate if performed on the same day as mastectomy followed by PMRT (I-AR or I-TE/I) or delayed if after PMRT (D-AR and D-TE/I). CRR was defined as an unplanned return to the operating room for infection, dehiscence, necrosis, hematoma, or hernia (with AR) and extrusion, leak, or contracture (with TE/I). RF was defined as unplanned conversion to another reconstruction technique or to flat chest wall. Cumulative incidence of CRR and RF was calculated using Kaplan-Meier and compared using the log-rank test. Logistic regression was used to identify variables associated with CRR and RF. RESULTS: Two hundred four patients were included. Median follow-up was 8 years. There were 127 AR cases (63%) and 77 TE/I cases (38%). At 5 years, CRR was 18%, 38%, 34%, and 70% (P = .010) and RF was 4%, 22%, 7%, and 56% (P < .0001) for I-AR, I-TE/I, D-AR, and D-TE/I, respectively. On multivariate analysis, TE/I (hazard ratio [HR] 2.0; P = .011), body mass index ≥30 (HR 3.9; P = .002), and smoking (HR 2.7; P = .001) were significant predictors for CRR, and TE/I (HR 6.6; P < .0001), diabetes (HR 4.1; P = .044), and hypertension (HR 3.5; P = .005) were significant for RF. When excluding RF because of infection, the rate of RF was not significantly different among the 4 groups (P = .23). CONCLUSIONS: With PMRT, TE/I reconstruction in the immediate and delayed setting is associated with higher CRR and RF compared with AR. Patient factors should guide selection of technique. Efforts to reduce rates of RF with TE/I should focus on minimizing risks for infection.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Manyam BV, Shah C, Woody NM, et al. Long-Term Outcomes After Autologous or Tissue Expander/Implant-Based Breast Reconstruction and Postmastectomy Radiation for Breast Cancer. Pract Radiat Oncol. 2019. PMID: 31238166. doi:10.1016/j.prro.2019.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。